MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
1.420
+0.020
+1.43%
After Hours: 1.440 +0.02 +1.41% 19:49 11/13 EST
OPEN
1.460
PREV CLOSE
1.400
HIGH
1.540
LOW
1.400
VOLUME
52.89K
TURNOVER
--
52 WEEK HIGH
22.20
52 WEEK LOW
1.255
MARKET CAP
11.89M
P/E (TTM)
-0.3217
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Femasys Announces Financial -2-
Dow Jones · 13h ago
Press Release: Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
Dow Jones · 13h ago
Femasys Insider Purchases Yet To Pay Off Regardless Of Recent Strength
Simply Wall St · 2d ago
Weekly Report: what happened at FEMY last week (1102-1106)?
Weekly Report · 5d ago
Rare Stock Picks In October 2026 - From 14 Discerning Analysts
Seeking Alpha · 11/04 13:00
Femasys Announces Board Director Appointment and Resignation
TipRanks · 11/02 22:11
Weekly Report: what happened at FEMY last week (1026-1030)?
Weekly Report · 11/02 09:24
*Femasys Appoints John Moorhead to Bd of Directors
Dow Jones · 10/30 13:01
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.